Effective nonapical left ventricular pacing with quadripolar leads for cardiac resynchronization therapy

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Current guidelines for cardiac resynchronization therapy (CRT) advise against apical left ventricular (LV) pacing.
• The need for alternative LV pacing sites is driven by potential complications and suboptimal outcomes associated with apical placement.

Purpose of the Study:

• To assess the feasibility of nonapical LV pacing using contemporary quadripolar LV lead systems.
• To evaluate the electrical parameters and safety of nonapical pacing positions with different quadripolar lead models.

Main Methods:

• Analysis of 168 patients undergoing CRT with quadripolar LV leads.
• Categorization of lead electrode positions as basal, mid, or apical post-implantation.
• Assessment of pacing capture threshold (PCT) and phrenic nerve stimulation (PNS) thresholds for each electrode.

Main Results:

• A significant proportion of patients had electrodes in nonapical segments across various lead manufacturers (Biotronik, Boston Scientific, St. Jude Medical).
• Most nonapical electrodes demonstrated adequate pacing capture thresholds and a sufficient safety margin concerning phrenic nerve stimulation.
• Phrenic nerve stimulation occurred in a small number of patients but was successfully managed through reprogramming, with no significant changes in pacing capture thresholds during follow-up.

Conclusions:

• Quadripolar LV leads facilitate nonapical pacing in a majority of CRT patients.
• Acceptable electrical parameters and safety margins were observed, though device-specific variations exist.
• Nonapical pacing represents a feasible strategy with current quadripolar lead technology, potentially expanding CRT optimization options.